Successful treatment of refractory focal eosinophilic myositis with extra-ocular muscle involvement using tocilizumab: a case report

• by Haijun Liu, Qianhua Li, Xia Ouyang, Shuyu Chen, Henglun Liang, Yufeng Ye, Huiyuan Cao, Yong Xue, Lie Dai

• May 25, 2026

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.

• by Andrea Surnit

• May 22, 2026

• 4 min

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.

• by Andrea Surnit

• May 22, 2026

• 4 min

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.

• by Kathryn Wighton

• May 18, 2026

• 2 min